In this regard, recently a combined strategy of tropism retargeting and tumor-restricted replication was applied by placing the essential immediate early α4 gene of a fully virulent HER2-retargeted oHSV under the control of the Survivin/BIRC5 promoter, which is highly transcribed in cell cycle phase G2 [142]. The gene discussed is BIRC5; the disease is neoplasm.